Table 5.

Point-of-care echocardiography data.

	COVID-19 ECMO survivors (n = 19)	COVID-19 ECMO non-survivors (n = 12)	p-value
TAPSE	1/14 (7.1%)	1/9 (11.1%)	0.74
RVSP	1/8 (12.5%)	0/5 (0.0%)	0.41
RV EDA/LV EDA	10/14 (71.4%)	6/9 (66.7%)	0.81
RV FAC	6/14 (42.9%)	3/9 (33.3%)	0.65
RVfwLS	4/14 (28.6%)	1/9 (11.1%)	0.32

Data are expressed as numbers (frequencies). A p-value <.05 is considered statistically significant.